Basic Information
| RNALocate ID: | RLID:11001013 |
| RNA Symbol: | hsa-miR-29b-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-29b-3p |
| RNA ID: | miRBase:MIMAT0000100 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001443 | Cytoplasm | HeLa cells | 28185889 |
| RLID:01001444 | Cytoplasm | Hepatic carcinoma cells (Huh-7) | 29253196 |
| RLID:01001445 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001446 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001447 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001448 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001449 | Nucleus | Hela cells|NIH-3T3 cells | 17204650 |
| RLID:01001450 | Nucleus | HeLa cells | 28185889 |
| RLID:01001451 | Nucleus | Hepatic carcinoma cells (Huh-7) | 29253196 |
| RLID:01001452 | Nucleus | HeLa cells | 30006350 |
| RLID:01001453 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001009 | Exosome | Urine | 26576778 |
| RLID:11001010 | Exosome | HCC tissues | 30542726 |
| RLID:11001011 | Exosome | Saliva | 19627513 |
| RLID:11001012 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001014 | Exosome | Plasma | 23663360 |
| RLID:11001015 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001016 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000034 | Exosome | Breast milk|Epithelial cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000299 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-29b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-35224 |
| MNDR | hsa-miR-29b-3p | Oral squamous cell carcinoma | MNDR-E-MI-35225 |
| MNDR | hsa-miR-29b-3p | Large cell neuroendocrine cancer | MNDR-E-MI-35226 |
| MNDR | hsa-miR-29b-3p | Medulloblastoma | MNDR-E-MI-35227 |
| MNDR | hsa-miR-29b-3p | B cell lymphoma of malt type | MNDR-E-MI-35228 |
| MNDR | hsa-miR-29b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-35229 |
| MNDR | hsa-miR-29b-3p | Ovarian clear cell carcinoma | MNDR-E-MI-35230 |
| MNDR | hsa-miR-29b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35231 |
| MNDR | hsa-miR-29b-3p | Spinocerebellar ataxia type 17 | MNDR-E-MI-35232 |
| MNDR | hsa-miR-29b-3p | Lymphoma | MNDR-E-MI-35233 |
| MNDR | hsa-miR-29b-3p | Non-hodgkin lymphoma | MNDR-E-MI-35234 |
| MNDR | hsa-miR-29b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-35235 |
| MNDR | hsa-miR-29b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35236 |
| MNDR | hsa-miR-29b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-35237 |
| MNDR | hsa-miR-29b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35238 |
| MNDR | hsa-miR-29b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-35239 |
| MNDR | hsa-miR-29b-3p | Breast cancer luminal | MNDR-E-MI-35240 |
| MNDR | hsa-miR-29b-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-35241 |
| MNDR | hsa-miR-29b-3p | Prostate cancer | MNDR-E-MI-35242 |
| MNDR | hsa-miR-29b-3p | Chronic lymphocytic leukemia | MNDR-E-MI-35243 |
| MNDR | hsa-miR-29b-3p | Gastric cancer | MNDR-E-MI-35244 |
| MNDR | hsa-miR-29b-3p | Alzheimer disease | MNDR-E-MI-35245 |
| MNDR | hsa-miR-29b-3p | Intracranial aneurysm | MNDR-E-MI-35246 |
| MNDR | hsa-miR-29b-3p | Sarcoma | MNDR-E-MI-35247 |
| MNDR | hsa-miR-29b-3p | Dysautonomia familial | MNDR-E-MI-35248 |
| MNDR | hsa-miR-29b-3p | Myotonic dystrophy | MNDR-E-MI-35249 |
| MNDR | hsa-miR-29b-3p | Duchenne muscular dystrophy | MNDR-E-MI-35250 |
| MNDR | hsa-miR-29b-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-35251 |
| MNDR | hsa-miR-29b-3p | Primary biliary cirrhosis | MNDR-E-MI-35252 |
| MNDR | hsa-miR-29b-3p | Leukemia | MNDR-E-MI-35253 |
| MNDR | hsa-miR-29b-3p | Huntington disease | MNDR-E-MI-35254 |
| MNDR | hsa-miR-29b-3p | Chorea | MNDR-E-MI-35255 |
| MNDR | hsa-miR-29b-3p | Cardiovascular disease | MNDR-E-MI-35256 |
| MNDR | hsa-miR-29b-3p | Uterine fibroid | MNDR-E-MI-35257 |
| MNDR | hsa-miR-29b-3p | Lung cancer | MNDR-E-MI-35258 |
| MNDR | hsa-miR-29b-3p | Down syndrome | MNDR-E-MI-35259 |
| MNDR | hsa-miR-29b-3p | Parkinson disease | MNDR-E-MI-35260 |
| MNDR | hsa-miR-29b-3p | Basal-like breast cancer | MNDR-E-MI-35261 |
| MNDR | hsa-miR-29b-3p | Thyroid cancer | MNDR-E-MI-35262 |
| MNDR | hsa-miR-29b-3p | Pancreatic cancer | MNDR-E-MI-35263 |
| MNDR | hsa-miR-29b-3p | Melanoma | MNDR-E-MI-35264 |
| MNDR | hsa-miR-29b-3p | Rectum adenocarcinoma | MNDR-E-MI-35265 |
| MNDR | hsa-miR-29b-3p | Nephroblastoma | MNDR-E-MI-35266 |
| MNDR | hsa-miR-29b-3p | Colon cancer | MNDR-E-MI-35267 |
| MNDR | hsa-miR-29b-3p | Ischemic attack transient | MNDR-E-MI-35268 |
| MNDR | hsa-miR-29b-3p | Colon adenocarcinoma | MNDR-E-MI-35269 |
| MNDR | hsa-miR-29b-3p | West nile virus infection | MNDR-E-MI-35270 |
| MNDR | hsa-miR-29b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35271 |
| MNDR | hsa-miR-29b-3p | Prostate adenocarcinoma | MNDR-E-MI-35272 |
| MNDR | hsa-miR-29b-3p | Kidney cancer | MNDR-E-MI-35273 |
| MNDR | hsa-miR-29b-3p | Thyroid adenomas | MNDR-E-MI-35274 |
| MNDR | hsa-miR-29b-3p | Carcinoma ductal breast | MNDR-E-MI-35275 |
| MNDR | hsa-miR-29b-3p | Glioblastoma | MNDR-E-MI-35276 |
| MNDR | hsa-miR-29b-3p | Astrocytoma | MNDR-E-MI-35277 |
| MNDR | hsa-miR-29b-3p | Glioma | MNDR-E-MI-35278 |
| MNDR | hsa-miR-29b-3p | Nemaline myopathy | MNDR-E-MI-35279 |
| MNDR | hsa-miR-29b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-35280 |
| MNDR | hsa-miR-29b-3p | Osteosarcoma | MNDR-E-MI-35281 |
| MNDR | hsa-miR-29b-3p | Liposarcoma | MNDR-E-MI-35282 |
| MNDR | hsa-miR-29b-3p | Meningioma | MNDR-E-MI-35283 |
| MNDR | hsa-miR-29b-3p | Uterine cancer | MNDR-E-MI-35284 |
| MNDR | hsa-miR-29b-3p | Stomach adenocarcinoma | MNDR-E-MI-35285 |
| MNDR | hsa-miR-29b-3p | Lung squamous cell carcinoma | MNDR-E-MI-35286 |
| MNDR | hsa-miR-29b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-35287 |
| MNDR | hsa-miR-29b-3p | Lung adenocarcinoma | MNDR-E-MI-35288 |
| MNDR | hsa-miR-29b-3p | Adrenocortical cancer | MNDR-E-MI-35289 |
| MNDR | hsa-miR-29b-3p | Thyroid carcinoma | MNDR-E-MI-35290 |
| MNDR | hsa-miR-29b-3p | Papillary thyroid carcinoma | MNDR-E-MI-35291 |
| MNDR | hsa-miR-29b-3p | Ovarian carcinoma | MNDR-E-MI-35292 |
| MNDR | hsa-miR-29b-3p | Bladder urothelial carcinoma | MNDR-E-MI-35293 |
| MNDR | hsa-miR-29b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-35294 |
| MNDR | hsa-miR-29b-3p | Brain stem cancer | MNDR-E-MI-35295 |
| MNDR | hsa-miR-29b-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-35296 |
| MNDR | hsa-miR-29b-3p | Carcinoma renal cell | MNDR-E-MI-35297 |
| MNDR | hsa-miR-29b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35298 |
| MNDR | hsa-miR-29b-3p | Renal clear cell carcinoma | MNDR-E-MI-35299 |
| MNDR | hsa-miR-29b-3p | Cholangiocarcinoma | MNDR-E-MI-35300 |
| MNDR | hsa-miR-29b-3p | Esophageal cancer | MNDR-E-MI-35301 |
| MNDR | hsa-miR-29b-3p | Oncocytoma | MNDR-E-MI-35302 |
| MNDR | hsa-miR-29b-3p | Lung small cell carcinoma | MNDR-E-MI-35303 |
| MNDR | hsa-miR-29b-3p | Schizophrenia | MNDR-E-MI-35304 |
| MNDR | hsa-miR-29b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-35305 |
| MNDR | hsa-miR-29b-3p | Testicular germ cell cancer | MNDR-E-MI-35306 |
| MNDR | hsa-miR-29b-3p | Breast invasive carcinoma | MNDR-E-MI-35307 |
| MNDR | hsa-miR-29b-3p | Hepatocellular carcinoma | MNDR-E-MI-35308 |
| MNDR | hsa-miR-29b-3p | Aggressive b-cell lymphoma | MNDR-E-MI-35309 |
| MNDR | hsa-miR-29b-3p | Rheumatoid arthritis | MNDR-E-MI-35310 |
| MNDR | hsa-miR-29b-3p | T-cell leukemia | MNDR-E-MI-35311 |
| MNDR | hsa-miR-29b-3p | Retinoblastoma | MNDR-E-MI-35312 |
| MNDR | hsa-miR-29b-3p | Neuroblastoma | MNDR-E-MI-35313 |
| MNDR | hsa-miR-29b-3p | Barrett's adenocarcinoma | MNDR-E-MI-35314 |
| MNDR | hsa-miR-29b-3p | Chronic myelogenous leukemia | MNDR-E-MI-35315 |
| MNDR | hsa-miR-29b-3p | Hodgkin lymphoma | MNDR-E-MI-35316 |
| MNDR | hsa-miR-29b-3p | Burkitt lymphoma | MNDR-E-MI-35317 |
| MNDR | hsa-miR-29b-3p | Tonsil cancer | MNDR-E-MI-35318 |
| MNDR | hsa-miR-29b-3p | Neuromyelitis optica | MNDR-E-MI-35319 |
| MNDR | hsa-miR-29b-3p | Acute myeloid leukemia | MNDR-E-MI-35320 |
| MNDR | hsa-miR-29b-3p | Frontotemporal dementia | MNDR-E-MI-35321 |
| MNDR | hsa-miR-29b-3p | Colorectal cancer | MNDR-E-MI-35322 |
| MNDR | hsa-miR-29b-3p | Nasopharynx carcinoma | MNDR-E-MI-35323 |
| MNDR | hsa-miR-29b-3p | Type 2 diabetes | MNDR-E-MI-35324 |
| MNDR | hsa-miR-29b-3p | Multiple myeloma | MNDR-E-MI-35325 |
| MNDR | hsa-miR-29b-3p | Ependymoma | MNDR-E-MI-35326 |
| MNDR | hsa-miR-29b-3p | Cardiomegaly | MNDR-E-MI-35327 |
| MNDR | hsa-miR-29b-3p | Nasopharyngeal cancer | MNDR-E-MI-35328 |
| MNDR | hsa-miR-29b-3p | Prostatic neoplasms | MNDR-E-MI-35329 |
| MNDR | hsa-miR-29b-3p | Acute myelogeneous leukemia | MNDR-E-MI-35330 |
| MNDR | hsa-miR-29b-3p | Aids dementia complex | MNDR-E-MI-35331 |
| MNDR | hsa-miR-29b-3p | Epstein-barr virus infections | MNDR-E-MI-35332 |
| MNDR | hsa-miR-29b-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-35333 |
| MNDR | hsa-miR-29b-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-35334 |
| MNDR | hsa-miR-29b-3p | Stroke lacunar | MNDR-E-MI-35335 |
| MNDR | hsa-miR-29b-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-35336 |
| MNDR | hsa-miR-29b-3p | Barrett's carcinogenesis | MNDR-E-MI-35337 |
| MNDR | hsa-miR-29b-3p | Breast cancer her3+ negative | MNDR-E-MI-35338 |
| MNDR | hsa-miR-29b-3p | Limb-girdle muscular dystrophies types 2A | MNDR-E-MI-35339 |
| MNDR | hsa-miR-29b-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-35340 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR2A | Homo sapiens | RR00039275 |
TOP